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Abstract
The advent of siRNA-based screens has revolutionized the efficiency by which functional components of biological
processes are identified. A notable exception has been the field of mammalian circadian rhythms. Here, we outline a
medium- to high-throughput siRNA-based approach that, in combination with real-time bioluminescence measurement of
a circadian reporter gene, can be utilized to elucidate the effects of gene knockdown across several days in human cells.
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Introduction
Circadian rhythms are ,24 h oscillations in behavior and
physiology present in most organisms that evolved as an
evolutionary response to the environmental changes brought upon
by the day-light cycle [1,2]. In mammals, the circadian system is
composed of a collection of tissue-independent, peripheral oscilla-
tors and a central pacemaker present in the Suprahiasmatic Nuclei
(SCN) of the hypothalamus. At the molecular level circadian
rhythms originate on a genetic circuit formed by two interlocked
transcription/translation feedback loops [3,4]. In one of these loops,
the bHLH-PAS transcription factors CLOCK and Bmal1 drive
expression of the Period (Per1 and Per2) and Cryptochrome (Cry1
and Cry2) genes, whose protein products inhibit CLOCK/Bmal1
activity, thus producing ,24 h rhythm in Per and Cry transcription.
In the second one, CLOCK/Bmal1 drive transcription of ROR and
Rev-erb class of nuclear hormone receptors, whose mutually-
opposing actionon the Bmal1 promoter produces ,24 h oscillations
in transcription of the Bmal1 gene. In all, the resulting oscillations in
CLOCK/Bmal1 activity give rise to global circadian rhythmicity.
The circadian clock generates rhythmic transcription of up to
10% of the genome and modulates major functions of almost every
organ [5,6]. Indeed, circadian dysfunction, whether due to
environmental or genetic factors, is associated with a plethora of
ailments in both animal models and humans, including metabolism
disorders, increased cancer incidence and abnormal aging
[5,7,8,9,10,11]. Furthermore, modern life circadian stressors, such
as shift work and jetlag, are estimated to have an economic impact
in the order of billions of dollars per year due to decrease
productivity, injuries and absenteeism [12].
Because of the influence of the oscillator on key biological
processes and its impact on human health and society, it has been
the subject of intense research. A large part of this impetus has been
directed towards understanding its molecular mode of action and,
importantly, its molecular components [13,14,15,16,17]. However,
as in other biological fields the discovery of new components based
on classical genetic tools, like mutagenesis screens or candidate gene
recombination-based disruption, is laborious and slow.
Within the past decade screening with focused and genome-scale
RNAi libraries has revolutionized the efficiency and speed by which
novel components in many biological processes are elucidated [18].
In contrast to other fields of biology, the use of large-scale siRNA
screens to identify novel components of the circadian clock has not
yet been achieved, primarily due to the difficulty in assay
miniaturization with a compatible plate reader, lack of easily
transfectable cell lines exhibiting robust circadian oscillations and
technical challenges in maintaining constant temperature and cell
culture conditions. We have overcome these challenges and
developed a robust high throughput-compatible bioluminescence
based assay that is amenable to siRNA based perturbation.
Rodent fibroblasts that are widely used for circadian cell-based
assays [19,20] typically exhibit very low transfection efficiencies.
Therefore, we developed a human osteosarcoma U2OS cell reporter
line (U2OS-B6) stably expressing a Bmal1 promoter-driven luciferase
reporter construct (Bmal1::Luc) that exhibits robust circadian
oscillations in bioluminescence. U2OS cells were selected because
of their successful use in siRNA gene knockdown experiments in high-
throughput assays using 384-well format [18,21,22]. These cells,
when plated in 35 mm culture dishes and monitored with a 32-
channel luminometer, exhibited robust bioluminescence rhythms that
persisted for up to 7 days (data not shown). However, the relatively
large culture dish size, longer integration time and limited number of
channels make this format unsuitable for HTS based screens.
Results
As a first step we set out to identify a temperature-controlled
luminescence plate reader with kinetic measurements feature. We
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2,500 and 40,000 cells per well in culture media (described below)
containing0.1 mMD-Luciferinandperformednon-invasivekinetic
bioluminescence measurement at 37uC. Of five different plate-
readers tested, TECAN luminometers provided the best signal-to-
noise ratio, temperature regulation and robustness in data
acquisition. However, irrespective of luminometers, the adhesive
optical tapes typically used to seal plates failed to maintain a proper
seal after two days of data collection, introducing significant well-to-
well variation in bioluminescence and/or cell survival. We found
sealing the plates with custom-made glass coverslips (see Materials
and Methods) and non-volatile ‘‘Dow Corning
R High Vacuum
Grease’’ remarkably improved signal uniformity and cell survival.
All cell density conditions exhibited almost equally robust
oscillations (data not shown). Based on a review of the literature
and on the recommendations of a number of manufacturers of
siRNA transfection reagents, we chose to develop a protocol based
on a density of 5,000 cells per well.
Next, we obtained a focused siRNA library comprising several
known clock components. In this library, each gene is individually
targeted by four different siRNAs. The logic of this approach is
two-fold: First, it enables us to make a preliminary assessment of
the significance of an effect based on whether it is observed with
different siRNA oligonucleotides. Second, as it is impractical to
validate the ability of each siRNA duplex to silence its target
mRNA before carrying out the screen, targeting each gene four
times enables us to prioritize hits for follow-up based on whether
different siRNAs give rise to a specific phenotype.
Each siRNA duplex was transfected in quadruplicate following
a reverse-transfection protocol, as outlined in Figure 1. The data
obtained for each well was detrended with a 24-h moving window
average and smoothed using a 2-hour moving average. Period
length and rhythmicity were determined by COSOPT analysis as
previously described [23]. COSOPT evaluates rhythmicity
through a statistical test, assigning a pMMC-beta value to each
well. In this assay, robustly rhythmic wells had a value of 0, while
arrhythmic ones were .0. The amplitude of each well’s
oscillations was defined as the difference between the 90th and
10th percentile.
After confirming the normality of the data by a Kolmogorov-
Smirnov test, hits were defined based on three criteria: (a)
Rhythmicity/arrhythmicity, (b) period length and (c) amplitude.
The period length and amplitude of each quadruplicate set were
tested for significant differences against 16 control wells (scrambled
siRNA) with a two-tailed Student’s t-test with a=0.05. A positive
hit was defined as a quadruplicate that is arrhythmic (.3 out of 4
wells show pMMC-beta value .0) or shows a significant difference
(p,0.05) in amplitude or period length against the control.
Since statistical measures to evaluate a high throughput screen
like the Z-factor [24] do not apply to our multidimensional
readout, we defined the false positive rate (FPR). To achieve this,
we utilized data from an entire plate transfected with scrambled
Figure 1. Schema of the kinetic 384-well siRNA assay timeline. Two days after transfection as described in the materials and methods, cells
are shocked and subjected to continuous luminescence measurements for 5 days, following which the data is detrended and analyzed.
doi:10.1371/journal.pone.0003457.g001
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‘‘samples.’’ False positives were then defined as hits according to
the criteria described above. Based on this, the average FPR of 25
independent randomizations was 10.1362.4% (mean6sd), which
is comparable to what other groups have reported [25,26].
To assess the unspecific effects of siRNA transfection we
compared the period length distribution between cells transfected
with a scrambled siRNA and untransfected cells. Transfection with
scrambled siRNA increased the variance of period length
distribution (Figure 2C), but did not affect the robustness of single
well oscillations (Figure 2A and B). Inter-plate variability in period
length (25.8260.97 h, n=4) and amplitude (106676, n=4) was
addressed by running scrambled siRNA transfected wells on every
screening plate.
Next, the siRNAs for Bmal1 and Cry1 were tested for knockdown
validation. These were chosen based on the clear phenotypes
observed in immortalized cells derived from homozygote-null
mutant mice [27,28]. Specifically, Bmal1 deficiency results in
complete disruption of circadian oscillations, while Cry1 disruption
leads to a period shortening phenotype coupled to severe
amplitude damping so that rhythmicity is lost in just over two
days [27].
Consistently, Bmal1 knockdown led to circadian rhythm
disruption and Cry1 to a short-period, with dampened oscillations
(Figure 3A and B). Q-PCR analysis of the siRNA-treated samples
showed a decrease of ,50% of the corresponding targeted
transcripts levels compared to our non-specific controls 48 hours
after transfection (Fig 3A and B, inlets). Finally, we also analyzed
the effect of knocking down a small set of known oscillator
components in this assay (Figure 3C and D). All the clock
components tested were scored as hits according to these criteria.
Importantly, circadian deficiencies observed in this 384 well based
siRNA knockdown mimic results from siRNA based knockdown in
35 mm culture dishes, fibroblasts from the respective knockout
Figure 2. Effect of siRNA transfection on U2OS-B6 cells. (A) individual traces and (B) average (with s.d.) of detrended luminescence counts
from wells with untransfected cells (left panel) or cells transfected with scrambled siRNA (right panel), n=250 per condition. (C) Frequency
distribution of the period length of both untransfected cells and cells transfected with scrambled siRNA shown in (A) and (B).
doi:10.1371/journal.pone.0003457.g002
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alleles of the respective genes [27,29].
Discussion
Until now the field of circadian biology has not fully benefited
from the power of siRNA-based discovery of novel oscillator
components. To address this, we have developed a method that is
cost-effective, reliable and that will likely prove valuable to the
study of the circadian oscillator for several reasons. First, this assay
is medium- to high-throughput compatible, thus allowing for
efficient and thorough screening for putative circadian clock genes.
Second, the approach makes use of transfection of synthetic
siRNA duplexes, circumventing the need for more complicated
strategies, such those involving lentiviral or retroviral vectors.
Third, this assay reveals clear circadian phenotypes caused by the
knockdown of several clock components, some of which (Bmal1,
Cry2, Per1) are similar to those observed in genetic-null murine
models. However, not all the phenotypes we observed are identical
to those of the corresponding knockout mouse cells. For example,
in this assay, Cry1 knockdown causes a dampened oscillation with
a shorter period length, whereas Cry1
2/2 murine fibroblast are
unable to sustain rhythms. These differences may be due to
incomplete Cry1 mRNA knockdown, the specific workings of
Figure 3. Assay validation. (A) Detrended luminescence traces of wells corresponding to either Bmal1 (left, n=4), Cry1 (right, n=4) or scrambled
control siRNA (gray traces, both panels, n=16). Relative mRNA (6s.d.) values were determined by Q-PCR (Inlets). (B) Detrended Luminescence traces
of wells transfected with different siRNAs specific for the indicated circadian oscillator components (n=4) or scrambled unspecific siRNA control wells
(n=16). (C) Amplitude and period length plots of the results obtained with siRNAs depicted in (a) and (b) (n=4, s.e.m). Multiples of s.e.m. of the
control siRNA (n=16) are indicated in gray boxes. Arrhythmic wells are displayed as open circles.
doi:10.1371/journal.pone.0003457.g003
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Nonetheless, it is interesting to note that both the free running
activity period of Cry1
2/2 mice, as well as that of SCN explants
derived from these animals is shortened compared to the wild-type
[27,30]. Overall, this cell-based system is suitable to study the
workings of the mammalian circadian oscillator. Furthermore,
given that U2OS cells are of human origin, they are an
appropriate stand-in in which to study the human clock. Finally,
while this work focuses on an siRNA-based method, this format
could be adapted for other strategies, such as small-molecule
library screening. Altogether, this work contributes to furthering
our understanding of the mechanisms of circadian regulation.
Materials and Methods
U2OS-B6 cells generation
U2OS cells were transfected with a plasmid harboring a
destabilized firefly luciferase (pGL4.22, Promega, Madison,
Wisconsin) construct under the control of the mBmal1 promoter
(2422 to +108). Stable cells were selected in DMEM plus 10%
FBS/1% Penicillin/Streptomycin and 2 and 2 mg/mL puromycin.
Clonal cell lines were then established by serial dilution and then
tested for the presence of circadian luciferase activity in a 32-
channel Lumicycle (Actimetrics).
Cell Culture and Transfections
U2OS-B6 cells were maintained under standard tissue culture
conditions in DMEM (Invitrogen) plus 10%FBS, 1% Penicillin/
Streptomycin and 2 mg/mL puromycin. For siRNA transfections,
a master mix of Serum- and Phenol Red-free DMEM (7 mL/
transfection), HiPerFect reagent (1 mL/transfection, Qiagen) and
2 mLo fa1 0 mM siRNA solution (2 pmols/transfection) was
distributed into each well of a 384-well plate and incubated at
room temperature for 20–40 minutes. During this time, U2OS-B6
cells were trypsinized and resuspended in Phenol Red-free DMEM
(Gibco, supplemented with 10% FBS, 15 mM HEPES pH 7.4,
non-essential amino acids, Sodium Pyruvate and 1% Penicillin/
Streptomycin/Antimycotic) to a concentration of 125,000 cells/
mL. Following incubation, 40 mL of cells were distributed onto
each well. Subsequently, the plates were covered, pulse centrifuged
and returned to a water-jacketed 37uC incubator. Forty-eight
hours after transfection, cells were shocked for 2 h at 37uCi na
final concentration of 100 nM dexamethasone. Following shock,
the medium was replaced with Phenol Red-free, supplemented
DMEM containing 100 mM D-Luciferin, sealed with a custom-
made glass coverslip (#1 borosilicate glass, 0.12–0.16 mm
thickness, 115677 mm area, Erie Scientific, Portsmouth, NH)
and subjected to real-time bioluminescence measurements for 5
days.
siRNAs, Plates, Reader and Data Acquisition
All siRNA duplexes were designed by and purchased from
Qiagen (Valencia, CA, sequences provided in Table S1). White,
flat-bottom, tissue culture-treated 384-well polystyrol Greiner
plates (11500 mm well depth) were read in a temperature-
controlled TECAN M200 Luminometer and iTecan Software
(Tecan Group, Ltd). The plate height was specified to 14400 mm
with a tolerance of 450 mm and luminescence for each well was
integrated over 2 seconds and read at 15-minute intervals for five
days at a temperature setting of 37uC. Data detrending and
smoothing were done in Excel 2007 (Microsoft, Seattle, WA) and
subsequently COSOPT analyzed as described in the text.
QPCR Analysis
Quantitative PCR was performed with ABI SYBR Green 26
Master Mix according to the manufacturer’s instructions with the
following primers: hBmal1 (F- 59-CAACCGCAAACG-
GAAAGGC-39;R -5 9-ACGCCGCTTTTCAATCTGACT-39),
hCry1 (F- 59-ACAGGTGGCGATTTTTGCTTC-39;R -5 9-
TCCAAAGGGCTCAGAATCATACT-39), hActb (F- 59-CAT
GTA CGT TGC TAT CCA GGC-39;R -5 9-CTC CTT AAT
GTC ACG CAC GAT-39).
Supporting Information
Table S1 siRNA duplex sequences in Excel format.
Found at: doi:10.1371/journal.pone.0003457.s001 (0.01 MB
DOC)
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